BR112020000120B1 - Uso de eritrulose, método de prevenir decaimento e decomposição microbianos, composição cosmética ou farmacêutica para aplicação tópica e processo para a preparação de uma composição - Google Patents

Uso de eritrulose, método de prevenir decaimento e decomposição microbianos, composição cosmética ou farmacêutica para aplicação tópica e processo para a preparação de uma composição Download PDF

Info

Publication number
BR112020000120B1
BR112020000120B1 BR112020000120-1A BR112020000120A BR112020000120B1 BR 112020000120 B1 BR112020000120 B1 BR 112020000120B1 BR 112020000120 A BR112020000120 A BR 112020000120A BR 112020000120 B1 BR112020000120 B1 BR 112020000120B1
Authority
BR
Brazil
Prior art keywords
erythrulose
composition
weight
cosmetic
range
Prior art date
Application number
BR112020000120-1A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112020000120A2 (pt
Inventor
Christine Mendrok-Edinger
Sebastien Mongiat
Thomas Rudolph
Original Assignee
Dsm Ip Assets B.V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets B.V filed Critical Dsm Ip Assets B.V
Publication of BR112020000120A2 publication Critical patent/BR112020000120A2/pt
Publication of BR112020000120B1 publication Critical patent/BR112020000120B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/064—Water-in-oil emulsions, e.g. Water-in-silicone emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
BR112020000120-1A 2017-07-06 2018-06-28 Uso de eritrulose, método de prevenir decaimento e decomposição microbianos, composição cosmética ou farmacêutica para aplicação tópica e processo para a preparação de uma composição BR112020000120B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17180056 2017-07-06
EP17180056.8 2017-07-06
PCT/EP2018/067368 WO2019007790A1 (en) 2017-07-06 2018-06-28 NEW USE

Publications (2)

Publication Number Publication Date
BR112020000120A2 BR112020000120A2 (pt) 2020-07-07
BR112020000120B1 true BR112020000120B1 (pt) 2023-03-28

Family

ID=59325141

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112020000120-1A BR112020000120B1 (pt) 2017-07-06 2018-06-28 Uso de eritrulose, método de prevenir decaimento e decomposição microbianos, composição cosmética ou farmacêutica para aplicação tópica e processo para a preparação de uma composição

Country Status (8)

Country Link
US (1) US11191772B2 (cg-RX-API-DMAC7.html)
EP (1) EP3648735B1 (cg-RX-API-DMAC7.html)
JP (1) JP7114847B2 (cg-RX-API-DMAC7.html)
KR (1) KR102630903B1 (cg-RX-API-DMAC7.html)
CN (1) CN110831570B (cg-RX-API-DMAC7.html)
BR (1) BR112020000120B1 (cg-RX-API-DMAC7.html)
ES (1) ES2932353T3 (cg-RX-API-DMAC7.html)
WO (1) WO2019007790A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020276652A1 (en) * 2019-05-10 2021-11-18 Dsm Ip Assets B.V. Topical compositions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE78166T1 (de) * 1985-10-22 1992-08-15 Silvetti Anthony N Monosaccharide enthaltende zusammensetzung zum heilen von wunden.
US6113888A (en) 1999-06-15 2000-09-05 Neutrogena Corporation Self-tanning mousse
WO2001072124A1 (en) 2000-03-28 2001-10-04 Nihon Starch Co., Ltd. Bacterial growth regulators or inhibitors with the use of 1,5-d-anhydrofructose
DE60329994D1 (de) * 2003-07-03 2009-12-24 Procter & Gamble Selbstbräuner enthaltend wasserlösliche Vitamin B3-Komponente und Bräunungswirkstoff mit Alpha-Hydroxycarbonyl-Gruppierung
DE102005036793A1 (de) 2005-08-02 2007-02-08 Merck Patent Gmbh Bräunungsverfahren
US20070122364A1 (en) * 2005-11-18 2007-05-31 Tatiana Kelly Self-tanning facial product having anti-wrinkle/anti-aging properties
US8206754B2 (en) 2007-05-30 2012-06-26 Conopco, Inc. Personal care composition with cocoa butter and dihydroxypropyl ammonium salts
US7780954B2 (en) * 2008-02-19 2010-08-24 Conopco, Inc. Glow and sunless tanning color enhancement by cationic copolymers
DE102010056550A1 (de) * 2010-12-30 2012-07-05 Evonik Goldschmidt Gmbh Verwendung von 13-Hydroxy-9, 11-octadecadiensäure zur Bräunung menschlicher Haut
US8747818B1 (en) * 2011-02-07 2014-06-10 Dennis Gross Self-tanning compositions
JP2012246228A (ja) 2011-05-25 2012-12-13 Atect Corp レジオネラ菌抗菌剤
US20130085461A1 (en) 2011-10-04 2013-04-04 Dermal Therapy (Barbados) Inc. Method for Pre-Debriding Treatment of Non-Viable Skin Tissue and Compositions and System Thereof
EP3494958B1 (en) * 2017-12-06 2020-07-29 DSM IP Assets B.V. Preservation booster

Also Published As

Publication number Publication date
JP2020525423A (ja) 2020-08-27
EP3648735B1 (en) 2022-10-12
EP3648735A1 (en) 2020-05-13
ES2932353T3 (es) 2023-01-18
CN110831570A (zh) 2020-02-21
KR20200026941A (ko) 2020-03-11
WO2019007790A1 (en) 2019-01-10
BR112020000120A2 (pt) 2020-07-07
US20200138841A1 (en) 2020-05-07
KR102630903B1 (ko) 2024-01-30
JP7114847B2 (ja) 2022-08-09
US11191772B2 (en) 2021-12-07
CN110831570B (zh) 2022-10-18

Similar Documents

Publication Publication Date Title
ES2937235T3 (es) Composiciones tópicas
ES2898925T3 (es) Monoacetato-mononitrato de propanodiol
KR102698105B1 (ko) 보존 증강제
JP7187740B2 (ja) 新規の使用
EP3709955A1 (en) Topical compositions
ES2932353T3 (es) Nuevo uso
BR112020000035B1 (pt) Composição tópica compreendendo eritrulose e caprilato de glicerila, usos de eritrulose e caprilato de glicerila e método de extermínio e/ou inibição de crescimento de p. acnes e c. albicans
BR112020009652B1 (pt) Composição tópica, uso da referida composição e uso de uma combinação de fitantriol e hidroxiacetofenona
ES3024707T3 (en) Topical compositions of phytantriol and p-hydroxyacetophenone
ES2657599T3 (es) Nuevas composiciones que comprenden p-hidroxibencilaminas
BR102018075165B1 (pt) Composição tópica e seu uso, uso de uma combinação de fitantriol e eritrulose e método cosmético para tratar a pele e/ou o couro cabeludo
EA040067B1 (ru) Мононитрат моноацетата пропандиола
AU2020276652A1 (en) Topical compositions

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 28/06/2018, OBSERVADAS AS CONDICOES LEGAIS